TY - JOUR
T1 - α-interferon in hematological malignancies
AU - Giles, Frank J.
AU - Ozer, Howard
PY - 1991/12
Y1 - 1991/12
N2 - Recent studies have generated data demonstrating significant clinical activity of α-interferon therapy in each of six hematological malignancies, chronic myeloid leukaemia, essential thrombocythemia, polycythemia rubra vera, non-Hodgkin's lymphomas, multiple myelomatosis and hairy cell leukaemia.
AB - Recent studies have generated data demonstrating significant clinical activity of α-interferon therapy in each of six hematological malignancies, chronic myeloid leukaemia, essential thrombocythemia, polycythemia rubra vera, non-Hodgkin's lymphomas, multiple myelomatosis and hairy cell leukaemia.
UR - http://www.scopus.com/inward/record.url?scp=0026309759&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=0026309759&partnerID=8YFLogxK
U2 - 10.1016/S0958-1669(05)80119-3
DO - 10.1016/S0958-1669(05)80119-3
M3 - Article
C2 - 1367959
AN - SCOPUS:0026309759
VL - 2
SP - 847
EP - 850
JO - Current Opinion in Biotechnology
JF - Current Opinion in Biotechnology
SN - 0958-1669
IS - 6
ER -